12:00 AM
 | 
Aug 22, 2011
 |  BC Week In Review  |  Company News  |  Other News

Avanir, Actavis, Par Pharmaceutical neurology news

Avanir filed a pair of suits in the U.S. District Court for the District of Delaware alleging that respective ANDAs filed by Actavis and Par for a generic version of the biotech's Nuedexta dextromethorphan/quinidine infringes U.S. Patent Nos. 7,659,282 and RE38,115. The ANDAs contain...

Read the full 207 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >